Why scientists think AI can catch early signs of the disease
Key Points:
- Researchers in Massachusetts are using artificial intelligence to identify early signs of Alzheimer’s disease, aiming to detect the illness during its mild cognitive impairment phase when symptoms are often unnoticed.
- Early detection is crucial as newer drugs can modestly slow the progression of Alzheimer’s if administered during these initial stages.
- Currently, 90 percent of individuals in the mild cognitive impairment phase remain undiagnosed in the U.S., highlighting a significant gap in early detection.
- Experts emphasize that improving Alzheimer’s care relies more on recognizing early symptoms sooner rather than solely developing new drugs.